Policy | June 25, 2026
NPPA integrates Pharma Jan Samadhan Portal with Pharma Sahi Daam Portal
Unified digital platform enables medicine price verification and grievance redressal in one place
Unified digital platform enables medicine price verification and grievance redressal in one place
Nuvectis gains global rights outside select Asian markets for oncology and complement disease therapies, with Haisco eligible for milestone payments and royalties
The company aims to make preventive and specialist healthcare as accessible as everyday retail experiences
34% of pharma firms have already deployed function-specific AI, with drug discovery, clinical trials, and medical writing emerging as key high-impact use cases
CDSCO-approved targeted therapy expands precision oncology options for patients with RET-driven lung, thyroid, and other advanced solid tumours
The company plans to use this funding to boost AI capabilities, expand vernacular content ecosystem, accelerate product development, and scale user acquisition across Tier 2 and Tier 3 markets
Intas Pharmaceuticals has appointed Girish Bhunje as Senior Vice President – API Operations
Rathi brings more than 15 years of experience in formulation research and development, with deep expertise across a wide range of dosage forms and drug delivery technologies.
The amendments notified under the Clinical Establishments Act, 2010 form part of this broader reform initiative aimed at creating a more responsive and facilitative regulatory ecosystem
With this commissioning, Shilpa Medicare joins a very small group of Indian companies capable of offering end-to-end ADC Drug Substance development and manufacturing
Subscribe To Our Newsletter & Stay Updated
